Align Sugar-binding transport ATP-binding protein aka MalK1 aka TT_C0211, component of The trehalose/maltose/sucrose/palatinose porter (TTC1627-9) plus MalK1 (ABC protein, shared with 3.A.1.1.24) (Silva et al. 2005; Chevance et al., 2006). The receptor (TTC1627) binds disaccharide alpha-glycosides, namely trehalose (alpha-1,1), sucrose (alpha-1,2), maltose (alpha-1,4), palatinose (alpha-1,6) and glucose (characterized)
to candidate WP_022528734.1 L248_RS03710 ABC transporter ATP-binding protein
Query= TCDB::Q72L52 (376 letters) >NCBI__GCF_000469325.1:WP_022528734.1 Length = 374 Score = 258 bits (659), Expect = 2e-73 Identities = 158/372 (42%), Positives = 208/372 (55%), Gaps = 6/372 (1%) Query: 4 VRLEHVWKRFGKVVAVKDFNLETEDGEFVVFVGPSGCGKTTTLRMIAGLEEISEGNIYIG 63 ++L H+ K FG + D +GEF V VGPSG GK+T LR+IAGL + G+IY Sbjct: 3 IQLTHLTKHFGDTPVLDDITATINEGEFYVLVGPSGSGKSTILRIIAGLIPATSGDIYFD 62 Query: 64 DRLVNDVPPKDRDIAMVFQNYALYPHMNVYENMAFGLRLRRYPKDEIDRRVKEAARILKI 123 D+ V D PKDR +AMVFQNYAL P M+V EN+ FGL + D RV +A +++ + Sbjct: 63 DKKVTDAAPKDRHLAMVFQNYALLPFMSVAENIRFGLHNLHLSTADEDARVADALQMVHL 122 Query: 124 EHLLNRKPRELSGGQRQRVAMGRAIVREPKVFLMDEPLSNLDAKLRVEMRAEIAKLQRRL 183 L +RKP+ELSGGQ+QRVA+ RAI + + LMDEPLSNLDA+LR EMR E+ +L + L Sbjct: 123 SDLADRKPKELSGGQQQRVAVARAIATQANLVLMDEPLSNLDAQLRTEMREELVELHKAL 182 Query: 184 GVTTIYVTHDQVEAMTLGHRIVVMKDGEIQQVDTPLNLYDFPANRFVAGFIGSPSMNFVR 243 +T IYVTHDQ EAMT+G RI+V+ D IQQV TPL LY+ P N FVA FIGSP MN Sbjct: 183 KMTLIYVTHDQTEAMTMGERIMVLNDHRIQQVGTPLELYNHPQNAFVATFIGSPKMNMFT 242 Query: 244 AGVEVQGEKVYLVAPGFRIRANAVLGSALKPYAGKEVWLGVRPEHLGLKGYTTIPEEENV 303 V+ + + L R + A P + LGVRPE + L + E Sbjct: 243 VTVDAAAKTITLPMVDEDGRPALIPLPAGIPSGTYQ--LGVRPEKVRL---SLASASEYD 297 Query: 304 LRGEVEVVEPLGAETEIHVAVNGTLLVAKVDGHAPVKPGDK-VELLADTQRLHAFDLETD 362 + V V LG + + V + +A + P V LH F +T Sbjct: 298 VPVTVVNVASLGRASNVAVKNSDVEFIADIAEQFPEDAAKAFVTFPTAAADLHFFAPDTG 357 Query: 363 RTIGHAQERAAV 374 + A E+A V Sbjct: 358 LAVTSAAEKAGV 369 Lambda K H 0.320 0.139 0.400 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 336 Number of extensions: 16 Number of successful extensions: 1 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 376 Length of database: 374 Length adjustment: 30 Effective length of query: 346 Effective length of database: 344 Effective search space: 119024 Effective search space used: 119024 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory